Last updated on June 2007

Pediatric Nevirapine Resistance Study


Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: AIDS | HIV Infections
  • Age: - 1 Years
  • Gender: Male or Female
  • Other:
    NVP-exposure as part of pMTCT-prophylaxis around delivery
    HIV-positive
    Eligible for treatment
    Plans to stay in the area for the next 6 months

You may not be eligible for this study if the following are true:

  • Already on anti-retroviral treatment
    History of toxicity to perinatal NVP
    Grade 3 or greater elevation of liver function tests
    Being treated for a severe acute opportunistic infection or tumor

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.